Establishment Labs (NASDAQ:ESTA) Hits New 1-Year Low - Here's What Happened

Shares of Establishment Labs Holdings Inc. (NASDAQ:ESTA - Get Free Report) hit a new 52-week low on Monday . The company traded as low as $29.87 and last traded at $31.03, with a volume of 104635 shares changing hands. The stock had previously closed at $32.05.

Analyst Ratings Changes

A number of research firms have issued reports on ESTA. Stephens upgraded Establishment Labs to a "strong-buy" rating in a research report on Monday, December 2nd. BTIG Research lifted their target price on Establishment Labs from $62.00 to $65.00 and gave the stock a "buy" rating in a report on Monday, October 14th. One research analyst has rated the stock with a hold rating, three have given a buy rating and one has issued a strong buy rating to the company's stock. According to MarketBeat, the company currently has a consensus rating of "Buy" and an average target price of $60.60.

Establishment Labs Stock Performance

The company has a quick ratio of 2.29, a current ratio of 3.62 and a debt-to-equity ratio of 5.94. The firm has a market capitalization of $847.56 million, a P/E ratio of -11.73 and a beta of 1.12. The company's 50 day moving average is $40.73 and its 200-day moving average is $42.32.

Establishment Labs (NASDAQ:ESTA - Get Free Report) last issued its earnings results on Thursday, November 7th. The company reported ($0.59) EPS for the quarter, beating the consensus estimate of ($0.61) by $0.02. The company had revenue of $40.23 million during the quarter, compared to the consensus estimate of $40.60 million. Establishment Labs had a negative return on equity of 184.55% and a negative net margin of 46.13%. During the same period last year, the business posted ($1.12) EPS. As a group, equities analysts anticipate that Establishment Labs Holdings Inc. will post -2.42 EPS for the current year.

Institutional Investors Weigh In On Establishment Labs

Hedge funds and other institutional investors have recently modified their holdings of the company. R Squared Ltd acquired a new stake in Establishment Labs in the 4th quarter valued at $36,000. Point72 Asia Singapore Pte. Ltd. acquired a new position in shares of Establishment Labs during the third quarter valued at about $127,000. Black Swift Group LLC bought a new stake in shares of Establishment Labs during the third quarter worth about $312,000. Handelsbanken Fonder AB raised its holdings in shares of Establishment Labs by 32.3% in the 4th quarter. Handelsbanken Fonder AB now owns 8,200 shares of the company's stock worth $378,000 after acquiring an additional 2,000 shares during the last quarter. Finally, Verition Fund Management LLC lifted its position in Establishment Labs by 22.8% in the 3rd quarter. Verition Fund Management LLC now owns 9,400 shares of the company's stock valued at $407,000 after acquiring an additional 1,746 shares in the last quarter. Institutional investors own 72.91% of the company's stock.

Establishment Labs Company Profile

Establishment Labs Holdings Inc, a medical technology company, manufactures and markets medical devices for aesthetic and reconstructive plastic surgery. The company primarily offers silicone gel-filled breast implants under the Motiva Implants brand. It also provides Motiva Ergonomix and Motiva Ergonomix2 gravity sensitive round soft silicone-gel-filled breast implants; and Motiva Flora Tissue Expander, a breast tissue expander.